Syngene International Gelecekteki Büyüme
Future kriter kontrolleri 3/6
Syngene International is forecast to grow earnings and revenue by 19.3% and 16% per annum respectively. EPS is expected to grow by 19.2% per annum. Return on equity is forecast to be 13.4% in 3 years.
Anahtar bilgiler
19.3%
Kazanç büyüme oranı
19.2%
EPS büyüme oranı
| Life Sciences kazanç büyümesi | 21.4% |
| Gelir büyüme oranı | 16.0% |
| Gelecekteki özkaynak getirisi | 13.4% |
| Analist kapsamı | Good |
| Son güncelleme | 28 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Why Syngene International's (NSE:SYNGENE) Shaky Earnings Are Just The Beginning Of Its Problems
Oct 31
Syngene International Limited's (NSE:SYNGENE) Popularity With Investors Is Under Threat From Overpricing
Jul 16These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Mar 28Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?
Feb 14Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)
Jan 19Is Syngene International (NSE:SYNGENE) A Risky Investment?
Nov 19Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?
Nov 01Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly
Aug 07These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Apr 28Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching
Apr 06Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Jan 04Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet
Dec 08Is Syngene International (NSE:SYNGENE) Using Too Much Debt?
Aug 28Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate
Aug 10These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well
May 10Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?
Feb 02Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Nov 26Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 3/31/2027 | 51,420 | 7,889 | 4,216 | 12,750 | 6 |
| 3/31/2026 | 44,410 | 6,725 | 3,486 | 11,399 | 8 |
| 3/31/2025 | 38,008 | 5,615 | 3,864 | 9,600 | 8 |
| 9/30/2024 | 34,511 | 4,819 | 4,740 | 9,589 | N/A |
| 6/30/2024 | 34,702 | 4,923 | N/A | N/A | N/A |
| 3/31/2024 | 34,886 | 5,100 | 5,313 | 10,421 | N/A |
| 12/31/2023 | 35,661 | 5,002 | N/A | N/A | N/A |
| 9/30/2023 | 34,985 | 4,984 | 4,706 | 10,290 | N/A |
| 6/30/2023 | 33,565 | 4,839 | N/A | N/A | N/A |
| 3/31/2023 | 31,929 | 4,644 | 3,052 | 8,235 | N/A |
| 12/31/2022 | 29,566 | 4,334 | N/A | N/A | N/A |
| 9/30/2022 | 28,121 | 4,277 | 1,083 | 5,898 | N/A |
| 6/30/2022 | 26,542 | 3,924 | N/A | N/A | N/A |
| 3/31/2022 | 26,042 | 3,958 | 1,051 | 5,806 | N/A |
| 12/31/2021 | 25,047 | 4,086 | N/A | N/A | N/A |
| 9/30/2021 | 24,478 | 4,068 | 2,102 | 6,566 | N/A |
| 6/30/2021 | 23,572 | 4,242 | N/A | N/A | N/A |
| 3/31/2021 | 21,843 | 4,049 | 2,547 | 7,012 | N/A |
| 12/31/2020 | 21,330 | 3,645 | N/A | N/A | N/A |
| 9/30/2020 | 20,676 | 3,541 | 1,217 | 6,318 | N/A |
| 6/30/2020 | 20,126 | 3,981 | N/A | N/A | N/A |
| 3/31/2020 | 20,119 | 4,121 | 340 | 6,771 | N/A |
| 12/31/2019 | 19,385 | 3,920 | N/A | N/A | N/A |
| 9/30/2019 | 18,865 | 3,872 | 1,257 | 7,549 | N/A |
| 6/30/2019 | 18,405 | 3,374 | N/A | N/A | N/A |
| 3/31/2019 | 18,256 | 3,316 | 471 | 6,304 | N/A |
| 12/31/2018 | 17,008 | 3,160 | N/A | N/A | N/A |
| 9/30/2018 | 16,214 | 3,110 | N/A | N/A | N/A |
| 6/30/2018 | 15,380 | 3,096 | N/A | N/A | N/A |
| 3/31/2018 | 14,231 | 3,054 | N/A | 4,462 | N/A |
| 12/31/2017 | 13,053 | 2,993 | N/A | N/A | N/A |
| 9/30/2017 | 12,497 | 2,917 | N/A | N/A | N/A |
| 6/30/2017 | 12,175 | 2,895 | N/A | N/A | N/A |
| 3/31/2017 | 12,009 | 2,873 | N/A | 3,977 | N/A |
| 12/31/2016 | 12,411 | 2,682 | N/A | N/A | N/A |
| 9/30/2016 | 11,894 | 2,606 | N/A | N/A | N/A |
| 6/30/2016 | 11,479 | 2,344 | N/A | N/A | N/A |
| 3/31/2016 | 11,070 | 2,408 | N/A | 3,081 | N/A |
| 12/31/2015 | 10,235 | 2,103 | N/A | N/A | N/A |
| 9/30/2015 | 9,713 | 1,964 | N/A | N/A | N/A |
| 6/30/2015 | 9,017 | 1,843 | N/A | N/A | N/A |
| 3/31/2015 | 8,599 | 1,750 | N/A | 185 | N/A |
| 3/31/2014 | 6,995 | 1,339 | N/A | 2,995 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: SYNGENE's forecast earnings growth (19.3% per year) is above the savings rate (6.7%).
Kazançlar ve Piyasa: SYNGENE's earnings (19.3% per year) are forecast to grow faster than the Indian market (18.1% per year).
Yüksek Büyüme Kazançları: SYNGENE's earnings are forecast to grow, but not significantly.
Gelir ve Pazar: SYNGENE's revenue (16% per year) is forecast to grow faster than the Indian market (10.2% per year).
Yüksek Büyüme Geliri: SYNGENE's revenue (16% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: SYNGENE's Return on Equity is forecast to be low in 3 years time (13.4%).